Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma
Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer
Micafungin Bests Fluconazole In Phase III Antifungal Trial
Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients
Navelbine+Herceptin: 78% Response In Breast Cancer
Substance From Sea Squirts In Phase II For Breast Cancer
Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds
More Surgical Patients Die When Nurse Caseloads Rise
Neural Stem Cells Track, Treat, Brain Tumors In Mice
Cancer Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Most Favored Nation drug pricing could put China on top
- Protecting the cure: Why the future of radiation oncology must be precision-guided
